
|Articles|February 15, 2004
Wavefront-guided LASIK yields positive results for hyperopia, astigmatism
Anaheim, CA-Wavefront-guided CustomCornea LASIK (Alcon) is yielding favorable early results in the ongoing FDA clinical trial evaluating its efficacy and safety for the treatment of hyperopia, hyperopic astigmatism, and mixed astigmatism, according to Omar J. Hakim, MD, FRCSC.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approvals in 2025: What changed and why it matters for ophthalmologists
2
PRIMAvera study: Central vision improvement with subretinal implant
3
Achieving a new level of refractive precision: Surgical strategies
4
Global trial equity: How LMIC data is reshaping US ophthalmology research
5




